Budget Impact Analysis of Dabrafenib and Trametinib Combination Therapy in The Treatment of Braf V600e-Mutant Advanced Non-Small Cell Lung Cancer in The United States
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.144
https://www.valueinhealthjournal.com/article/S1098-3015(17)30478-3/fulltext
Title :
Budget Impact Analysis of Dabrafenib and Trametinib Combination Therapy in The Treatment of Braf V600e-Mutant Advanced Non-Small Cell Lung Cancer in The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30478-3&doi=10.1016/j.jval.2017.08.144
First page :
A422
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
124